Stocks
CONMED (CNMD) EBITDA margin US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 17.7% | 0.75% | 15.5% | 20.8% | 14.1% | 15.4% | ||
| Changes by years, y/y, % | +5pp | -17pp | +15pp | +5pp | -7pp | +1.3% | |||
CONMED. EBITDA margin, %
CONMED. EBITDA margin, changes, pp
CONMED (CNMD) EBITDA margin US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | 7.64% | 16.0% | 9.59% | 23.0% | 12.1% | 15.4% | |
| Changes by years, y/y, % | -9pp | -4pp | -17pp | +3pp | +4pp | |||
| Changes by quarters, q/q, % | -13pp | +8pp | -6pp | +13pp | -11pp | |||
